» Articles » PMID: 2571355

Amplification and Expression of Mdr1 Gene in a Multidrug Resistant Variant of Small Cell Lung Cancer Cell Line NCI-H69

Overview
Journal Br J Cancer
Specialty Oncology
Date 1989 Sep 1
PMID 2571355
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Amplification and expression of the mdr1 gene encoding P-glycoprotein have been studied in H69/LX4 a multidrug resistant variant (MDR) of small cell lung cancer (SCLC) cell line NCI-H69. Recently a second independently derived MDR variant of this cell line designated H69/AR was found by others not to show amplification, rearrangement or over-expression of the mdr1 gene. The present study reports that in marked contrast to H69/AR, H69/LX4 shows amplification and expression of the P-glycoprotein gene and raises the possibility that P-glycoprotein hyperexpression may be a clinically relevant component of MDR in some SCLC tumours.

Citing Articles

A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance.

Zahra R, Furqan M, Ullah R, Mithani A, Saleem R, Faisal A PLoS One. 2020; 15(6):e0233993.

PMID: 32484843 PMC: 7266297. DOI: 10.1371/journal.pone.0233993.


Exploiting microRNAs As Cancer Therapeutics.

Robb T, Reid G, Blenkiron C Target Oncol. 2017; 12(2):163-178.

PMID: 28138797 DOI: 10.1007/s11523-017-0476-7.


The Roles of MicroRNAs in Breast Cancer.

Takahashi R, Miyazaki H, Ochiya T Cancers (Basel). 2015; 7(2):598-616.

PMID: 25860815 PMC: 4491673. DOI: 10.3390/cancers7020598.


Chromosome microdissection identifies genomic amplifications associated with drug resistance in a leukemia cell line: an approach to understanding drug resistance in cancer.

Mahjoubi F, Hill R, Peters G Chromosome Res. 2006; 14(3):263-76.

PMID: 16628497 DOI: 10.1007/s10577-006-1042-9.


Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma.

Wood L, Palmer M, Hewitt J, Urtasun R, Bruera E, Rapp E Br J Cancer. 1998; 77(4):627-31.

PMID: 9484821 PMC: 2149923. DOI: 10.1038/bjc.1998.100.


References
1.
Safa A, Glover C, MEYERS M, Biedler J, Felsted R . Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J Biol Chem. 1986; 261(14):6137-40. View

2.
Scotto K, Biedler J, Melera P . Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science. 1986; 232(4751):751-5. DOI: 10.1126/science.2421411. View

3.
Shen D, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S . Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem. 1986; 261(17):7762-70. View

4.
Roninson I, Chin J, Choi K, Gros P, Housman D, Fojo A . Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A. 1986; 83(12):4538-42. PMC: 323769. DOI: 10.1073/pnas.83.12.4538. View

5.
Willingham M, Cornwell M, Cardarelli C, Gottesman M, Pastan I . Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Res. 1986; 46(11):5941-6. View